A study by (72), determined that genomic abnormalities not only correlate between isolated CTCs and the tumour of origin, but also revealed the maintenance of epidermal growth factor receptor (EGFR) amplification in CTCs, indicating sustained growth potential. The gene discussed is EGFR; the disease is neoplasm.